Therapy Areas: Oncology
Telix and Ekalia to develop US astatine-211 production
...
GSK reports 61% response rate for investigational lung cancer drug
19 October 2026 - Biopharmaceutical company GSK plc (LSE: GSK) (NYSE: GSK) on Monday reported a confirmed overall response rate of 61% for its investigational antibody-drug conjugate risvutatug rezete...
IBA and Framatome establish joint venture to scale up Astatine-211 production
16 October 2026 - Particle accelerator technology company Ion Beam Applications S.A. (IBA) (Euronext Brussels:IBAB) announced on Friday that together with French nuclear energy company Framatome it ha...
Expression Therapeutics awarded USD2m grant to advance potential new therapy for children with high-risk neuroblastoma
16 October 2026 - Expression Therapeutics Inc, a clinical-stage gene and cell therapy company, announced on Thursday that it has been awarded a National Cancer Institute (NCI) Small Business Innovatio...
SenderraRx receives reaccreditation in Specialty Pharmacy from ACHC
16 October 2026 - SenderraRx, an independent specialty pharmacy, announced on Thursday that it has earned reaccreditation in Specialty Pharmacy from the Accreditation Commission for Health Care (ACHC)...
EMA issues positive CHMP opinion for Revolution Medicines' RASONQUE in metastatic pancreatic cancer
15 October 2026 - US-based oncology company Revolution Medicines, Inc. (NASDAQ: RVMD) on Thursday said it has received a positive opinion from the European Medicines Agency's Committee for Medici...